INBX Buy Disclosure
Kayyem Jon Faiz · SEC Form 4 · Filed Sep 17, 2026
Buy
Calculated transaction value
$500K
Kayyem Jon Faiz Director
INBX
Inhibrx Biosciences
INBX
Transaction date
Sep 16, 2026
Public filing date
Sep 17, 2026
Filing lag
Filed 1 day later
INBX daily price context
Close on/before transaction
$101.77
Sep 16, 2026
Close before public filing
$101.77
Sep 16, 2026
Return since public filing
+7.45%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 5,000 shares @ $100
- SEC ownership
- Indirect
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001366268-26-000006
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$500K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Inhibrx Biosciences, Inc. INBX Current | Buy | Sep 16, 2026 | $500K |